Komen N, de Bruin R W F, Kleinrensink G J, Jeekel J, Lange J F
Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Colorectal Dis. 2008 Feb;10(2):109-15; discussion 115-7. doi: 10.1111/j.1463-1318.2007.01430.x.
Colorectal anastomotic leakage (AL) is a severe complication leading to severe infection, sepsis and sometimes death. At present the diagnosis is made clinically, usually at 6-8 days after surgery. An objective biomarker reflecting the intra-abdominal milieu surrounding the anastomosis would be a useful additional diagnostic tool to make the diagnosis of AL before its clinical presentation. This review aims to assess the current status of the search for such a biomarker in peritoneal fluid.
A literature search was carried out, using MEDLINE, PubMed and the Cochrane library, for all publications concerning human peritoneal fluid in relation to postoperative complications in general, and, more specific, anastomotic leakage after colorectal surgery.
Analysis of several immune parameters, tissue repair parameters, parameters for ischaemia and microbiological composition of peritoneal fluid show that these can be determined reliably in the fluid, albeit with a large variance. Furthermore the data show that changes in concentration of these parameters precede AL and other postoperative complications by several days.
The results of the review demonstrate that it is possible to distinguish between patients with and without AL by measuring biomarkers in fluid from the peritoneal drain. Prospective studies with larger numbers of patients should, however, be performed and additional biomarkers should be studied to explore the full diagnostic potential of this approach.
结直肠吻合口漏(AL)是一种严重并发症,可导致严重感染、脓毒症,有时甚至死亡。目前,诊断通常在临床上进行,一般在术后6 - 8天。一种能够反映吻合口周围腹腔内环境的客观生物标志物,将是在AL临床表现之前进行诊断的一种有用的辅助诊断工具。本综述旨在评估在腹膜液中寻找此类生物标志物的现状。
利用MEDLINE、PubMed和Cochrane图书馆进行文献检索,查找所有关于人类腹膜液与一般术后并发症,更具体地说是结直肠手术后吻合口漏相关的出版物。
对腹膜液的几种免疫参数、组织修复参数、缺血参数和微生物组成的分析表明,这些参数在液体中能够可靠地测定,尽管存在很大差异。此外,数据表明这些参数浓度的变化比AL和其他术后并发症提前几天出现。
综述结果表明,通过测量腹膜引流液中的生物标志物,有可能区分有或没有AL的患者。然而,应该进行更多患者的前瞻性研究,并研究其他生物标志物,以探索这种方法的全部诊断潜力。